Literature DB >> 8555751

The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.

D L Sultzer1, M E Mahler, M A Mandelkern, J L Cummings, W G Van Gorp, C H Hinkin, M A Berisford.   

Abstract

Cognitive and noncognitive psychiatric symptoms were systematically evaluated in 21 patients with Alzheimer's disease by using the Neurobehavioral Rating Scale. Regional cerebral metabolic activity was measured in each patient by [18F]fluorodeoxyglucose PET. Significant correlations emerged between global cortical metabolic activity and the Agitation/Disinhibition factor score, Cognition factor score, and total score. Relationships between noncognitive symptoms and metabolic activity were regionally specific, with significant correlations between Agitation/Disinhibition factor score and metabolism in the frontal and temporal lobes, between Psychosis factor score and metabolism in the frontal lobe, and between Anxiety/Depression factor score and metabolism in the parietal lobe. These results suggest that psychiatric symptoms are fundamental expressions of the cortical dysfunction of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8555751     DOI: 10.1176/jnp.7.4.476

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  28 in total

1.  The neurobehavioural rating scale-revised: sensitivity and validity in closed head injury assessment.

Authors:  S R McCauley; H S Levin; M Vanier; J M Mazaux; C Boake; P R Goldfader; D Rockers; M Butters; D A Kareken; J Lambert; G L Clifton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

2.  Executive dysfunction in Alzheimer disease.

Authors:  Margaret M Swanberg; Rochelle E Tractenberg; Richard Mohs; Leon J Thal; Jeffrey L Cummings
Journal:  Arch Neurol       Date:  2004-04

3.  Neurobiology of delusions, memory, and insight in Alzheimer disease.

Authors:  David L Sultzer; Lorraine P Leskin; Rebecca J Melrose; Dylan G Harwood; Theresa A Narvaez; Timothy K Ando; Mark A Mandelkern
Journal:  Am J Geriatr Psychiatry       Date:  2013-09-08       Impact factor: 4.105

4.  Neuropsychiatric symptoms in Alzheimer's disease.

Authors:  Constantine G Lyketsos; Maria C Carrillo; J Michael Ryan; Ara S Khachaturian; Paula Trzepacz; Joan Amatniek; Jesse Cedarbaum; Robert Brashear; David S Miller
Journal:  Alzheimers Dement       Date:  2011-09       Impact factor: 21.566

5.  β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis.

Authors:  Patrick S Murray; Caitlin M Kirkwood; Megan C Gray; Milos D Ikonomovic; William R Paljug; Eric E Abrahamson; Ruth A Henteleff; Ronald L Hamilton; Julia K Kofler; William E Klunk; Oscar L Lopez; Peter Penzes; Robert A Sweet
Journal:  Neurobiol Aging       Date:  2012-03-17       Impact factor: 4.673

Review 6.  Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.

Authors:  Kentaro Hirao; Gregory M Pontone; Gwenn S Smith
Journal:  Neurosci Biobehav Rev       Date:  2014-11-20       Impact factor: 8.989

7.  Cerebral correlates of psychotic symptoms in Alzheimer's disease.

Authors:  M S Mega; L Lee; I D Dinov; F Mishkin; A W Toga; J L Cummings
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

8.  TAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis.

Authors:  Anil Varma V Vatsavayi; Julia Kofler; Mary Ann A Demichele-Sweet; Patrick S Murray; Oscar L Lopez; Robert A Sweet
Journal:  Int Psychogeriatr       Date:  2014-03-04       Impact factor: 3.878

9.  Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.

Authors:  Paula T Trzepacz; Peng Yu; Phani K Bhamidipati; Brian Willis; Tammy Forrester; Linda Tabas; Adam J Schwarz; Andrew J Saykin
Journal:  Alzheimers Dement       Date:  2012-12-17       Impact factor: 21.566

Review 10.  Psychosis in Alzheimer's disease.

Authors:  Patrick S Murray; Sanjeev Kumar; Mary Ann A Demichele-Sweet; Robert A Sweet
Journal:  Biol Psychiatry       Date:  2013-10-06       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.